Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

European stocks higher; German consumer price increases slow

Published 2023-02-09, 04:16 a/m
© Reuters.
EUR/USD
-
UK100
-
FCHI
-
DE40
-
CSGN
-
AZN
-
ULVR
-
MT
-
GC
-
LCO
-
CL
-

By Peter Nurse 

Investing.com - European stock markets traded higher Thursday, boosted by a slowing in the growth of German consumer prices while investors digested a flood of quarterly corporate earnings.

At 03:55 ET (08:55 GMT), the DAX index in Germany traded 1.1% higher, the CAC 40 in France gained 1.2%, while the FTSE 100 in the U.K. climbed 0.6%.

German consumer prices, harmonized to compare with other European Union countries, rose by a less-than-anticipated 9.2% on the year in January and by 0.5% on the month, according to preliminary data Thursday.

Analysts had expected this release to grow by 10.0% on an annual basis and increase by 1.2% on the previous month.

Investors, both in Europe and the U.S., have been searching for signs that inflation is peaking, so central bankers can start reining in their aggressive interest rate hikes.

The European Central Bank raised interest rates by half a percentage point last week and signaled a move of the same size for next month. 

"If underlying inflation pressures do not materially abate, maintaining the current pace of hikes into May could well remain warranted," ECB policymaker Klaas Knot said on Wednesday.

Elsewhere, the quarterly earnings season continued unabated.

Credit Suisse (SIX:CSGN) stock slumped 5.6% after the scandal-hit Swiss lender booked an annual loss of CHF 7.29 billion (CHF1 = $1.0881), the worst mark since the 2008 financial crisis and its second-straight yearly loss.

ArcelorMittal (AS:MT) stock rose 0.6% after the world's second-largest steelmaker reported fourth-quarter core profit of $1.26B, down from $5.05B a year before, but said it expects its steel shipments to increase by around 5% this year.

AstraZeneca (LON:AZN) stock rose 3.9% after the drugmaker beat expectations with fourth-quarter profits, despite lower-than-expected sales of its best-selling oncology and rare blood disorder drugs plus a decline in sales of its COVID-19 vaccine. 

Unilever (LON:ULVR) stock rose 0.3% after the consumer goods group reported sales growth that was only slightly below estimates in the fourth quarter, as higher prices helped offset inflation-linked weakness in customer demand and elevated expenses.

Oil prices steadied Thursday near two-week highs, despite U.S. crude stocks hitting their highest level for months, raising fears of weakening demand in the world's largest economy.

Crude oil stocks in the United States rose 5 million barrels last week to their highest since June 2021, the Energy Information Administration said on Wednesday. 

By 03:55 ET, U.S. crude futures rose 0.3% to $78.71 a barrel, while the Brent contract rose 0.4% to $85.42. 

Both contracts are up over 3% this week on optimism over a demand recovery in China and following supply disruptions caused by an earthquake in Turkey and Syria.

Additionally, gold futures traded 0.3% higher at $1,895.80/oz, while EUR/USD traded 0.4% higher at 1.0752.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.